From GlobeNewswire: 2025-05-22 08:19:00

Innovative IBS Treatment: Biomerica’s inFoods® IBS product shows real-world results with a 48.5% reduction in GI pain and 49.8% reduction in bloating over 8 weeks. A new feedback system empowers physicians to adjust treatment based on patient outcomes, offering a personalized, non-drug solution. This addresses a major market need as IBS affects 10-15% of adults in the U.S., reducing quality of life and productivity. The system identifies individual food triggers, improving IBS management for patients and healthcare providers. Real-world findings align with prior clinical trials and have been published in Gastroenterology, showing significant symptom relief.



Read more at GlobeNewswire: Biomerica Reports Real-World Data Showing 49% Reduction in